IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 195 filers reported holding IMMUNOGEN INC in Q4 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $48,000 | +128.6% | 9,354 | +3.7% | 0.00% | – |
| Q3 2019 | $21,000 | +23.5% | 9,023 | +8.4% | 0.00% | – |
| Q2 2019 | $17,000 | -19.0% | 8,320 | +5.5% | 0.00% | – |
| Q1 2019 | $21,000 | -66.1% | 7,888 | -38.7% | 0.00% | -100.0% |
| Q4 2018 | $62,000 | -50.0% | 12,876 | -2.0% | 0.00% | 0.0% |
| Q3 2018 | $124,000 | 0.0% | 13,145 | +3.0% | 0.00% | -50.0% |
| Q2 2018 | $124,000 | -10.8% | 12,764 | -3.1% | 0.00% | 0.0% |
| Q1 2018 | $139,000 | +58.0% | 13,173 | -4.3% | 0.00% | +100.0% |
| Q4 2017 | $88,000 | 0.0% | 13,759 | +18.1% | 0.00% | 0.0% |
| Q3 2017 | $88,000 | -1.1% | 11,649 | -6.6% | 0.00% | -50.0% |
| Q2 2017 | $89,000 | +178.1% | 12,471 | +52.3% | 0.00% | +100.0% |
| Q1 2017 | $32,000 | +128.6% | 8,190 | +20.2% | 0.00% | – |
| Q4 2016 | $14,000 | -12.5% | 6,816 | +13.9% | 0.00% | – |
| Q3 2016 | $16,000 | -27.3% | 5,985 | -17.2% | 0.00% | -100.0% |
| Q2 2016 | $22,000 | – | 7,232 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |